Atovaquone and Proguanil Hydrochloride 62.5 mg/1 (Atovaquone and Proguanil Hydrochloride TABLET, FILM COATED) 62.5 mg/1

Atovaquone and Proguanil Hydrochloride 62.5 mg/1 is a combination medication used for malaria prevention and treatment. This oral tablet is formulated to provide effective protection against malaria-causing parasites.

Strength

62.5 mg/1

Pack Size

100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-4160-01)

Manufacturer / TM Owner

Mylan Pharmaceuticals Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Atovaquone and Proguanil Hydrochloride is primarily used for the prevention and treatment of malaria. It is often prescribed for travelers to areas where malaria is prevalent. The medication works by interfering with the growth of parasites in the red blood cells, thereby helping to prevent or manage malaria infections.

Side Effects

Common effects of Atovaquone and Proguanil Hydrochloride may include nausea, vomiting, diarrhea, and headache. Some users might experience abdominal pain or loss of appetite. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

Precautions & Warnings

Atovaquone and Proguanil Hydrochloride should be used with caution in individuals with severe kidney or liver problems. It is important to follow the prescribed dosage and complete the full course of treatment. Pregnant women and those with a history of severe allergic reactions to similar medications should consult their healthcare provider before use.

Avoid Interactions

Atovaquone and Proguanil Hydrochloride may interact with certain medications, including antacids, metoclopramide, and drugs that affect liver enzymes. Alcohol consumption should be avoided as it may reduce the effectiveness of the medication. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Atovaquone and Proguanil Hydrochloride is used for the prevention and treatment of malaria, particularly in areas where the disease is prevalent.

Atovaquone and Proguanil Hydrochloride is taken orally, typically with food or a milky drink to enhance absorption.

Common side effects include nausea, vomiting, diarrhea, headache, and abdominal pain. These effects are usually mild and temporary.

Pregnant women should consult their healthcare provider before taking Atovaquone and Proguanil Hydrochloride to assess the benefits and risks.

It is advisable to avoid alcohol while taking Atovaquone and Proguanil Hydrochloride as it may reduce the medication's effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.